Efficacy analysis of epidermal growth factor receptor tyrosine kinase inhibitor in first-line treatment of locally advanced or metastatic non-small cell lung cancer with epidermal growth factor receptor sensitive mutations

doi:10.3969/j.issn.1672-3384.2025.09.012

Liping SONG, Can ZHAO, Yujiao ZHOU, Boyang YAO, Xue WANG, Pingchao XIANG

Clinical Medication Journal ›› 2025, Vol. 23 ›› Issue (9) : 71-76.

PDF(593 KB)

Clinical Medication Journal ›› 2025, Vol. 23 ›› Issue (9) : 71-76. DOI: 10.3969/j.issn.1672-3384.2025.09.012

Original Article

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 23(9): 71-76 https://doi.org/10.3969/j.issn.1672-3384.2025.09.012

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(593 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2025-05-06	2025-09-10
Issue Date
2025-09-26

Please choose a citation manager

Content to export